🧬 Omics-Insights: Your Weekly Genomics & Proteomics Digest 🧬
Welcome to our latest Omics newsletter, your portal for the freshest updates and innovations in genomics. This week's newsletter brings you the latest updates from the dynamic world of Omics. In this edition, we bring you the latest developments in the dynamic world of Omics, including key industry news, strategic collaborations, skill development essentials for finding a new job, & essential career tips for omics professionals.
This week's latest news in the field of Life Science:
🧠 Alzheimer’s Drug Discovery Foundation Invests $10M in Alamar Biosciences to Revolutionize Alzheimer’s Diagnostics
The Alzheimer’s Drug Discovery Foundation (ADDF) is making waves in Alzheimer’s diagnostics with a groundbreaking $10M investment in Alamar Biosciences. This marks the largest investment in the history of ADDF’s Diagnostics Accelerator (DxA), aimed at accelerating the development of the ARGO-HT system. This innovative platform will provide in vitro diagnostic (IVD) tests to help clinicians better diagnose Alzheimer’s disease and related dementias. Alamar’s technology promises ultra-sensitive blood-based biomarker detection, a crucial step in personalizing treatment for Alzheimer’s patients. The ADDF’s vision of accessible and scalable diagnostics for Alzheimer’s is progressing with this partnership, ensuring more accurate diagnosis and paving the way for new treatments. #Alzheimers #PrecisionMedicine #Diagnostics #HealthcareInnovation
💸 Geneoscopy Secures $105M in Series C Funding to Launch Noninvasive Colon Cancer Test
Geneoscopy has successfully raised $105M in a Series C financing round, led by Bio-Rad Laboratories, to fund the launch of its noninvasive colorectal cancer screening test, ColoSense. This test uses Bio-Rad's Droplet Digital PCR to detect RNA biomarkers from stool samples, offering an at-home, FDA-approved method for colorectal cancer and adenoma detection. With a growing need for early colorectal cancer screening, especially for individuals over 45, this investment supports the development of solutions that prioritize patient well-being and advance gastrointestinal health. The company also aims to develop additional diagnostic tests for inflammatory bowel disease. #ColorectalCancer #RNA #HealthTech #MedicalInnovation
🩸 Oxford Cancer Analytics Raises $11M for Liquid Biopsy Technology
Oxford Cancer Analytics has raised $11M in a Series A funding round, led by We Venture Capital and Cross-Border Impact Ventures. The company specializes in liquid biopsy tests for early cancer detection, focusing on proteomics and machine-learning technologies to identify cancer biomarkers. The lead product, a protein-based blood test for high-risk lung cancer, aims to provide a non-invasive, early diagnostic tool for clinicians. The new funding will support the commercialization of this promising technology. #CancerDetection #LiquidBiopsy #Proteomics #HealthInnovation
📝 Platomics Partners with Agilent and Sophia Genetics for IVDR Compliance Automation
Platomics has launched a pilot program with Agilent Technologies to automate the regulatory compliance documentation for next-generation sequencing tests under the European Union’s In Vitro Diagnostic Regulation (IVDR). Additionally, Platomics has partnered with Sophia Genetics to streamline the compliance process for clinical laboratories using Sophia's products. These collaborations aim to simplify the documentation workflow, providing researchers with essential data to meet IVDR standards. #IVDRCompliance #NGS #RegulatoryTech #HealthcarePartnerships
🧬 Ultima Genomics Selected for UK Biobank’s Groundbreaking Human Proteome Study
Ultima Genomics’ UG 100™ sequencing platform has been selected to power the UK Biobank’s largest-ever proteomics study. The study will explore how protein fluctuations during mid- to late-life influence disease progression, with the goal of advancing personalized medicine. This initiative, involving 600,000 samples, will quantify over 5,400 protein markers and provide unprecedented insights into disease mechanisms, enabling the development of diagnostic and therapeutic solutions. #Proteomics #PersonalizedMedicine #NextGenSequencing #Biobank
🔬 PacBio Delivers Vega Systems to Berry Genomics for Clinical Assay Development in Asia
PacBio has delivered its first Vega systems to Berry Genomics, marking a significant milestone in clinical assay development. This collaboration will enable Berry to develop targeted assays for prenatal, newborn, and carrier screening in China and beyond. With plans for regulatory review and over 50 Vega units purchased, this partnership promises to enhance genomics accessibility and innovation in the Asian markets. #Genomics #ClinicalAssays #BiotechInnovation #AsiaMarket
Get Ready for the 2025 J.P. Morgan Healthcare Conference – Coming Next Week!
🚀 The 2025 J.P. Morgan Healthcare Conference is just around the corner, happening next week from January 14-18 in San Francisco. As one of the largest and most influential events in the healthcare and life sciences sector, this conference is a must-attend for industry leaders, innovators, and investors looking to stay ahead of the curve in the rapidly evolving healthcare landscape.
🌍 What to Expect:
📅 Whether you're attending in person or following the updates from afar, the 2025 J.P. Morgan Healthcare Conference is set to be an exciting event full of valuable insights and transformative ideas that will shape the future of healthcare. Make sure to mark your calendars!
#JPHealthcare2025 #BiotechInnovation #HealthcareConference #LifeSciences #Networking
Current Live Roles at Kinetica:
VP of Sales - Bioprocess - UK
Senior Account Manager - NGS Reagents - LA
Business Development Manager - NGS - DACH
Business Development Manager - Proteomics - Nordics
Sales Manager - Genomics Reagents - UK
Sales Director - Genomic Data Analysis - US
Senior Marketing Manager - Life Science - Cambridge
Account Manager - Proteomics - Scotland
Account Manager - Proteomics - Oxford
Account Manager - Proteomics Ireland
Job Hunting Tips from an Omics Specialist Recruiter: How to Search for a New Job in 2025 After the Holiday Season
🔍 1. Start Fresh with a Clean Resume The new year is a perfect time to refresh your resume. After the holidays, employers are gearing up for new hiring cycles. Take a moment to update your skills, achievements, and projects from 2024. Highlight any certifications, new technologies you’ve mastered, and your impact on previous roles. Tailoring your resume to each job application, especially in specialized areas like genomics and omics, will set you apart from other candidates.
🌐 2. Leverage Networking and Industry Events While everyone’s winding down during the holidays, now’s the time to rekindle professional relationships. The beginning of the year is when new job opportunities and collaborations are often shared. Attend virtual or in-person networking events, like the J.P. Morgan Healthcare Conference or sector-specific webinars, to meet recruiters, hiring managers, and potential collaborators in the Omics space. Don’t hesitate to reach out to your professional network to inquire about opportunities.
🔑 3. Focus on Niche Omics Platforms In 2025, many companies in the omics space are focusing on cutting-edge areas like single-cell sequencing, spatial biology, and genomic data analysis. If you’re looking for a role in these niches, make sure to stay up-to-date with the latest technologies. Tailor your job search to platforms or companies that specialize in advanced technologies that align with your skill set.
💡 4. Stay Current with Industry Trends The start of the year is when many companies set their strategies and goals for the future. Stay informed about the latest breakthroughs in omics technologies, the impact of AI on genomics, and any mergers or acquisitions that could shape the industry. Understanding these trends can help you target companies that are actively expanding and hiring in 2025.
👥 5. Partner with a Specialist Recruiter Working with a recruiter who specializes in omics can help you identify job openings that might not be widely advertised. Recruiters in your field have a deep understanding of the unique requirements for positions in genomics, biotechnology, and life sciences, and they can connect you with roles that match your expertise. Plus, they can offer valuable interview coaching and feedback.
📅 6. Set Realistic Goals and Expectations After the holiday season, it’s easy to get overwhelmed by the number of job postings out there. Stay focused by setting clear, measurable job-search goals: how many jobs to apply for each week, how many networking connections to make, and how often to follow up on applications. A structured approach will help keep you motivated and organized.
💬 7. Don’t Hesitate to Reach Out Directly If there’s a company or position you're particularly interested in, don’t wait for a job posting. Reach out to hiring managers, HR departments, or recruiters to express your interest. In the competitive world of omics and genomics, proactive outreach can make a big difference. Customize your message to showcase your knowledge of their work and explain how your skills align with their needs.
2025 is a year of opportunity in the Omics space, with exciting advancements and innovations shaping the future of genomics, biotechnology, and personalized medicine. By taking these steps to restart your job search after the holiday season, you'll be well on your way to landing a role that aligns with your goals and expertise in the coming year.
Good luck, and happy job hunting! 🌟
#JobSearchTips #OmicsSpecialist #GenomicsCareers #2025JobHunt #LifeSciences
Wrapping Up Another Omics-Insights:
Thank you for embarking on a journey into the dynamic world of Omics with Kinetica! Explore the latest genomics job opportunities, stay informed with industry news, and indulge in insightful blogs at www.kinetica.co.uk. Your curiosity drives my commitment to relevant content, and I'm here to provide insights that fuel your scientific endeavors. Feel free to reach out with any questions or feedback. Wishing you ongoing inspiration and discovery in your scientific pursuits. Until next week, may your experiments yield groundbreaking results, and may your Omics journey remain as fascinating as science!
#alzheimersresearch #alzheimersdiagnostics #biomarkerdiscovery #precisionmedicine #healthcareinnovation #medicalbreakthroughs #neurology #dementiacare #alzheimersawareness #innovativeplatforms #bloodbasedtests #diagnostictechnologies #patientcare #earlydiagnosis #personalizedtreatment #genomicdiagnostics #noninvasivecancer #healthtech #cancerscreening #liquidbiopsy #proteomics